VetMedGuide

Vet Med Guide

Companion animal in a veterinary exam setting with medication reference materials.
Pharmaceuticals2026-06-16 · 9 min read

Ozempic, Wegovy, and GLP-1 Drugs in Pets: Poisoning Signs and What to Do

GLP-1 weight-loss and diabetes drugs like Ozempic, Wegovy, and Mounjaro are poisoning more pets as household use rises. Here are the signs, the treatment, and how to prevent an accidental exposure.

Ran Chen
Ran Chen
Founder, VetMedGuide. Life-sciences operator and 10× global market-access lead.
Published

GLP-1 receptor agonists — the injectable and oral drugs behind Ozempic, Wegovy, Mounjaro, and several other blockbuster weight-loss and type 2 diabetes medications — have moved into tens of millions of American households over the last few years. As the prescriptions have spread, so have accidental pet exposures. In March 2026 the ASPCA issued a formal "pet safety alert" about rising GLP-1 exposures in dogs and cats, and the drugs now appear alongside classic hazards on poison-control watch lists.

None of these medications are approved for veterinary use, and pets do not handle them the way people do. Most one-time exposures cause gastrointestinal upset and resolve with supportive care. But the weekly injectable pens carry a large dose in a small, chewable plastic device, and the consequences of a serious exposure — hypoglycemia, pancreatitis — are exactly the kind of problem where a few hours matter.

Here is what the current evidence says about GLP-1 poisoning in dogs and cats, how it is treated, and how to keep it from happening.

What GLP-1 Drugs Are, and Which Ones Matter

GLP-1 (glucagon-like peptide-1) receptor agonists mimic a hormone that slows stomach emptying, blunts appetite, and helps the body release insulin in response to meals. In people they are prescribed for type 2 diabetes and chronic weight management. The common drugs, and the brand names pet owners will recognize on a package or pen, are:

  • Semaglutide — Ozempic (diabetes), Wegovy (weight loss), Rybelsus (oral tablet)
  • Tirzepatide — Mounjaro (diabetes), Zepbound (weight loss); this is a dual GLP-1/GIP agonist
  • Liraglutide — Victoza (diabetes), Saxenda (weight loss), a once-daily injection
  • Dulaglutide — Trulicity, a once-weekly injection

Two features drive the poisoning risk. First, several of these are long-acting weekly injections, so a single pen holds a large total dose concentrated in a few milliliters of liquid. Second, GLP-1 drugs are formulated as a liquid inside a plastic pen device that many dogs find chewable — and a chewed pen can deliver the entire week's dose at once. The pens also leave residue at the injection site and on used needles, which curious pets may lick.

Why GLP-1 Drugs Affect Pets Differently

Animals metabolize medications differently from humans, and GLP-1 agonists are no exception. The mechanisms that make these drugs effective in people — slowing gastric emptying and amplifying insulin release — are exactly what make an overdose unpleasant or dangerous in a pet.

The most consistent effect in exposed pets is gastrointestinal: vomiting, diarrhea, lethargy, and a drop in appetite. Slowed stomach emptying contributes to nausea. In more serious cases, two specific complications can follow:

  • Hypoglycemia (low blood sugar). GLP-1 drugs amplify insulin release. In a healthy, fasted pet the effect is usually modest, but the risk rises when a large dose is ingested, when the pet is diabetic and already on insulin, or when food intake drops because of nausea.
  • Pancreatitis. Because GLP-1 drugs stress the pancreas, inflammation of the pancreas is a recognized though uncommon complication of significant exposure.

The clinical picture in a pet therefore looks a lot like the human side-effect profile — nausea, vomiting, reduced appetite — but amplified by dose and by the pet's smaller size and different metabolism.

How Pets Are Actually Exposed

The exposure patterns reported by the ASPCA Animal Poison Control Center and Pet Poison Helpline fall into a few recognizable categories:

  • Chewing injectable pens. A dog that finds a pen on a nightstand, in a purse, or in the trash can puncture it and ingest the concentrated solution. This is one of the highest-risk scenarios because a single weekly pen can contain many times a human therapeutic dose.
  • Licking the injection site or a used pen. Pets that groom their owner's skin, or that investigate a discarded pen in the wastebasket, can receive a smaller but still meaningful dose.
  • Eating oral tablets. Rybelsus and compounded oral products are tablets; a dropped pill or an open bottle is a familiar access route, similar to other human medication poisonings.
  • Accidental therapeutic mix-ups. Pet Poison Helpline has documented cases in which a diabetic pet that was supposed to receive insulin was instead accidentally injected with a household member's semaglutide pen. Because the pet was already insulin-dependent, the effects were severe — in one published case a Siberian Husky given multiple Ozempic doses by a pet sitter instead of her insulin was hospitalized for two days with hypoglycemia before recovering. The risk is practical, not theoretical: Ozempic autoinjector pens look much like the pen-style insulin devices many diabetic pets use, and both are commonly stored together in the refrigerator.
  • Intentional misuse. Veterinarians and toxicologists have flagged a social-media-driven trend — sometimes called "Ozempets" or "Ozempups" — of owners giving human weight-loss drugs to pets. This is unsafe: these drugs have no established dose, safety, or efficacy for companion animals.

Clinical Signs to Watch For

Most exposures that reach a veterinarian produce some combination of:

  • Vomiting
  • Diarrhea
  • Lethargy
  • Decreased or absent appetite

Signs that point to a more serious exposure and warrant urgent care include:

  • Weakness, trembling, or collapse (possible hypoglycemia)
  • Seizures (hypoglycemia can progress to seizures, particularly in small dogs or diabetic pets)
  • Abdominal pain, repeated vomiting, or a hunched posture (possible pancreatitis — see pancreatitis in dogs)
  • Yellowing of the gums, skin, or whites of the eyes

Onset is usually within hours. Because the long-acting injectables are designed to last a full week, signs and the need for monitoring can be prolonged rather than brief.

Cats are not spared. They are smaller and often more sensitive on a per-pound basis, and a pen or tablet that would only upset a medium dog's stomach can cause more pronounced illness in a cat. Both species warrant the same call-the-vet response.

Diagnosis

There is no specific blood test that says "semaglutide." Diagnosis is built from:

  1. A credible exposure history — what was ingested or injected, roughly how much, and when. Bringing the packaging, the pen, or the remaining tablets to the clinic is genuinely useful.
  2. A physical exam and baseline blood work, including blood glucose and a chemistry panel.
  3. Targeted testing when complications are suspected — a blood glucose curve or point-of-care glucose for hypoglycemia, and a pancreatic lipase (cPL) test when pancreatitis is a concern.

The combination of exposure history and consistent clinical signs is usually enough to act on; the lab work tells the veterinary team how sick the pet is and what supportive care to prioritize.

Treatment

There is no antidote for GLP-1 poisoning. Treatment is supportive, and the right move starts before the pet reaches the clinic: call a veterinarian or a pet poison hotline first.

What owners should do immediately

  • Call your veterinarian or an emergency animal hospital right away. A pet poison hotline — the ASPCA Animal Poison Control Center at 888-426-4435 or Pet Poison Helpline at 855-764-7661 — can triage the exposure and advise whether the pet needs to be seen.
  • Do not induce vomiting unless a veterinarian or poison-control professional tells you to. With injectable GLP-1 drugs the medication is already absorbed, and inducing vomiting adds dehydration risk on top of nausea.
  • Bring the packaging. The drug name, strength, and whether it was an injectable pen or a tablet determine how aggressively to monitor.

Supportive care at the clinic

  • Fluid therapy and anti-nausea medication for the gastrointestinal phase. Drugs such as maropitant (see Cerenia for dogs) are commonly used to control vomiting.
  • Blood glucose monitoring, with intravenous dextrose if hypoglycemia develops.
  • Pain control and supportive treatment for pancreatitis when the pancreatic enzymes are elevated — usually IV fluids, analgesia, and a carefully managed return to food.
  • Observation, which for the long-acting injectables may need to extend beyond a single day because the drug's effects persist.

Prognosis

For a typical one-time exposure treated promptly, the outlook is good: most pets experience self-limiting GI upset and recover. Prognosis worsens with large ingestions (a chewed weekly pen), with repeated exposures, and when the pet is diabetic and the GLP-1 drug interacts with its insulin regimen. As with most toxicities, the decisive variable is time — pets do better the earlier treatment begins.

Prevention

  1. Store injectable pens and tablets in closed cabinets or drawers, not on nightstands, counters, or in purses or backpacks a pet can reach.
  2. Dispose of used pens safely. A sharps container — not the household trash — keeps used pens away from dogs that raid garbage cans.
  3. Inject away from pets and recap needles immediately. Do not let a pet groom the injection site right after a dose.
  4. Do not store GLP-1 pens next to insulin pens in the refrigerator. The autoinjector pens look alike, and grabbing the wrong one for a diabetic pet is exactly the mix-up that has caused the most severe reported exposures.
  5. Never give a human GLP-1 drug to a pet. There is no safe owner-determined dose, and the "Ozempup" trend is not a veterinary treatment.
  6. Keep the poison-hotline numbers visible. ASPCA Animal Poison Control Center: 888-426-4435. Pet Poison Helpline: 855-764-7661. A consultation fee usually applies, but the triage is worth it.

What to Ask Your Veterinarian

If an exposure has happened, the questions that change the plan are concrete: How much was ingested or injected, and over what window? Does my pet need to be hospitalized for monitoring because the drug is long-acting? What blood values will you check, and when should I expect a follow-up? If your pet is diabetic and may have received the wrong injection, tell the clinic immediately — that changes both the glucose strategy and the urgency.

Sources

Topics
Drug Safety & ToxicologyEmergency & Critical Care
Related Articles